Clinical trial
A Trial of Rosiglitazone for Ulcerative Colitis
NCT00065065 · James Lewis, Other · Completed
Key facts
| NCT number | NCT00065065 |
|---|---|
| Title | A Trial of Rosiglitazone for Ulcerative Colitis |
| Official title | A Randomized, Placebo-controlled Trial of Rosiglitazone for Treatment of Ulcerative Colitis |
| Lead sponsor | James Lewis, Other |
| Collaborators | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) NIH GlaxoSmithKline Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Ulcerative Colitis, Inflammatory Bowel Disease |
| Intervention type | Drug |
| Interventions | Rosiglitazone, Placebo |
| Enrollment | 105 |
| Start date | Sep 1, 2002 |
| Primary completion | Jan 1, 2008 |
| Completion | Jan 1, 2008 |
| First posted | Jul 18, 2003 |
| Last update posted | Jan 16, 2018 |
| Countries | United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: